Literature DB >> 22371116

Growth of Mycobacterium tuberculosis biofilms.

Kathleen Kulka1, Graham Hatfull, Anil K Ojha.   

Abstract

Mycobacterium tuberculosis, the etiologic agent of human tuberculosis, has an extraordinary ability to survive against environmental stresses including antibiotics. Although stress tolerance of M. tuberculosis is one of the likely contributors to the 6-month long chemotherapy of tuberculosis (1), the molecular mechanisms underlying this characteristic phenotype of the pathogen remain unclear. Many microbial species have evolved to survive in stressful environments by self-assembling in highly organized, surface attached, and matrix encapsulated structures called biofilms (2-4). Growth in communities appears to be a preferred survival strategy of microbes, and is achieved through genetic components that regulate surface attachment, intercellular communications, and synthesis of extracellular polymeric substances (EPS) (5,6). The tolerance to environmental stress is likely facilitated by EPS, and perhaps by the physiological adaptation of individual bacilli to heterogeneous microenvironments within the complex architecture of biofilms (7). In a series of recent papers we established that M. tuberculosis and Mycobacterium smegmatis have a strong propensity to grow in organized multicellular structures, called biofilms, which can tolerate more than 50 times the minimal inhibitory concentrations of the anti-tuberculosis drugs isoniazid and rifampicin (8-10). M. tuberculosis, however, intriguingly requires specific conditions to form mature biofilms, in particular 9:1 ratio of headspace: media as well as limited exchange of air with the atmosphere (9). Requirements of specialized environmental conditions could possibly be linked to the fact that M. tuberculosis is an obligate human pathogen and thus has adapted to tissue environments. In this publication we demonstrate methods for culturing M. tuberculosis biofilms in a bottle and a 12-well plate format, which is convenient for bacteriological as well as genetic studies. We have described the protocol for an attenuated strain of M. tuberculosis, mc(2)7000, with deletion in the two loci, panCD and RD1, that are critical for in vivo growth of the pathogen (9). This strain can be safely used in a BSL-2 containment for understanding the basic biology of the tuberculosis pathogen thus avoiding the requirement of an expensive BSL-3 facility. The method can be extended, with appropriate modification in media, to grow biofilm of other culturable mycobacterial species. Overall, a uniform protocol of culturing mycobacterial biofilms will help the investigators interested in studying the basic resilient characteristics of mycobacteria. In addition, a clear and concise method of growing mycobacterial biofilms will also help the clinical and pharmaceutical investigators to test the efficacy of a potential drug.

Entities:  

Mesh:

Year:  2012        PMID: 22371116      PMCID: PMC3376936          DOI: 10.3791/3820

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG_1351) in CIS-cyclopropanation of alpha-mycolates.

Authors:  Laeticia Alibaud; Anuradha Alahari; Xavier Trivelli; Anil K Ojha; Graham F Hatfull; Yann Guerardel; Laurent Kremer
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 3.  Chemotherapy and diagnosis of tuberculosis.

Authors:  Cesare Saltini
Journal:  Respir Med       Date:  2006-12       Impact factor: 3.415

Review 4.  Biofilm formation and dispersal and the transmission of human pathogens.

Authors:  Luanne Hall-Stoodley; Paul Stoodley
Journal:  Trends Microbiol       Date:  2005-01       Impact factor: 17.079

Review 5.  Biofilms: the matrix revisited.

Authors:  Steven S Branda; Shild Vik; Lisa Friedman; Roberto Kolter
Journal:  Trends Microbiol       Date:  2005-01       Impact factor: 17.079

Review 6.  Bacterial social engagements.

Authors:  Jennifer M Henke; Bonnie L Bassler
Journal:  Trends Cell Biol       Date:  2004-11       Impact factor: 20.808

7.  GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria.

Authors:  Anil Ojha; Mridula Anand; Apoorva Bhatt; Laurent Kremer; William R Jacobs; Graham F Hatfull
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

8.  One for all and all for one.

Authors:  R Kolter; R Losick
Journal:  Science       Date:  1998-04-10       Impact factor: 47.728

9.  Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.

Authors:  Amina Jindani; Caroline J Doré; Denis A Mitchison
Journal:  Am J Respir Crit Care Med       Date:  2003-01-06       Impact factor: 21.405

10.  Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum.

Authors:  L Hall-Stoodley; H Lappin-Scott
Journal:  FEMS Microbiol Lett       Date:  1998-11-01       Impact factor: 2.742

View more
  29 in total

1.  Zafirlukast inhibits complexation of Lsr2 with DNA and growth of Mycobacterium tuberculosis.

Authors:  Lucile Pinault; Jeong-Sun Han; Choong-Min Kang; Jimmy Franco; Donald R Ronning
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

Review 2.  Tuberculosis vaccine types and timings.

Authors:  Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

3.  Identification of Anti-Mycobacterial Biofilm Agents Based on the 2-Aminoimidazole Scaffold.

Authors:  T Vu Nguyen; Bradley M Minrovic; Roberta J Melander; Christian Melander
Journal:  ChemMedChem       Date:  2019-03-21       Impact factor: 3.466

4.  Histone methyltransferase SUV39H1 participates in host defense by methylating mycobacterial histone-like protein HupB.

Authors:  Imtiyaz Yaseen; Mitali Choudhury; Manjula Sritharan; Sanjeev Khosla
Journal:  EMBO J       Date:  2017-11-23       Impact factor: 11.598

5.  Tailoring Trehalose for Biomedical and Biotechnological Applications.

Authors:  Mara K O'Neill; Brent F Piligian; Claire D Olson; Peter J Woodruff; Benjamin M Swarts
Journal:  Pure Appl Chem       Date:  2017-01-11       Impact factor: 2.453

Review 6.  Multispecies biofilms and host responses: "discriminating the trees from the forest".

Authors:  R Peyyala; J L Ebersole
Journal:  Cytokine       Date:  2012-11-06       Impact factor: 3.861

7.  Anti-biofilm activity of quinazoline derivatives against Mycobacterium smegmatis.

Authors:  Karlie E Cox; Christian Melander
Journal:  Medchemcomm       Date:  2019-05-23       Impact factor: 3.597

8.  Resuscitation-Promoting Factors Are Required for Mycobacterium smegmatis Biofilm Formation.

Authors:  Christopher Ealand; Binayak Rimal; James Chang; Lethabo Mashigo; Melissa Chengalroyen; Lusanda Mapela; Germar Beukes; Edith Machowski; Sung Joon Kim; Bavesh Kana
Journal:  Appl Environ Microbiol       Date:  2018-08-17       Impact factor: 4.792

Review 9.  Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection.

Authors:  Wanessa C M A de Melo; Pinar Avci; Milene Nóbrega de Oliveira; Asheesh Gupta; Daniela Vecchio; Magesh Sadasivam; Rakkiyappan Chandran; Ying-Ying Huang; Rui Yin; Livia R Perussi; George P Tegos; Janice R Perussi; Tianhong Dai; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-07       Impact factor: 5.091

Review 10.  Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease.

Authors:  William Walkowski; Justin Bassett; Manmeet Bhalla; Blaine A Pfeifer; Elsa N Bou Ghanem
Journal:  Vaccines (Basel)       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.